Clinical Trial Update: Methylene Blue Treatment of Chronic Hepatitis B Virus Infection [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating methylene blue as a treatment for chronic hepatitis B infection. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Fondazione Epatocentro Ticino | Conditions: Chronic HBV Infection | Phase 2 | Status: RECRUITING